mirtazapine has been researched along with oxidopamine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Bouvard, M; Rénéric, JP; Stinus, L | 1 |
| Grasso, SA; Holtz, NA; Napier, TC; Persons, AL; Tedford, SE | 1 |
| Asanuma, M; Kagawa, D; Kikuoka, R; Kitamura, Y; Kubota, N; Maeda, M; Miyazaki, I; Moriyama, M; Murakami, S; Sato, A; Sendo, T | 1 |
4 other study(ies) available for mirtazapine and oxidopamine
| Article | Year |
|---|---|
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
In the rat forced swimming test, NA-system mediated interactions may prevent the 5-HT properties of some subacute antidepressant treatments being expressed.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Biogenic Monoamines; Brain; Depression; Dopamine Agents; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Immobilization; Male; Mianserin; Mirtazapine; Motor Activity; Norepinephrine; Oxidopamine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Swimming | 2002 |
Pharmacologically distinct pramipexole-mediated akinesia vs. risk-taking in a rat model of Parkinson's disease.
Topics: Animals; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Benzothiazoles; Corpus Striatum; Delay Discounting; Dopamine Agonists; Dose-Response Relationship, Drug; Impulsive Behavior; Male; Mianserin; Mirtazapine; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pramipexole; Random Allocation; Rats, Sprague-Dawley; Risk-Taking; Self Stimulation | 2016 |
Mirtazapine exerts astrocyte-mediated dopaminergic neuroprotection.
Topics: Animals; Antioxidants; Astrocytes; Cells, Cultured; Dopamine; Dopaminergic Neurons; Female; Male; Metallothionein; Mice; Mice, Inbred ICR; Mirtazapine; Neuroprotection; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Parkinson Disease; Pregnancy; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Substantia Nigra | 2020 |